Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

That would be an incredible development but IMO it's not realistic given how low our market value is and the fact we had to dilute at an all time low stock price. They sold 20% of the company for $20m. If Lombardo had even been able to get $20m upfront in a AXAL deal that would have been preferable to what he did. So it begs the question is there not much interest in AXAL or was Lombardo simply an unmotivated terrible deal maker.